Age-Related Macular Degeneration Market Insights: Information by Type (Wet Age-Related Macular Degeneration (Wet AMD) and Dry Age-Related Macular Degeneration (Dry AMD)) Stage (Intermediate Stage Age-Related Macular Degeneration, Early-Stage Age-Related Macular Degeneration and Late Stage Age-Related Macular Degeneration) Age Group (Above 75 years, Above 6s0 years and Above 40 years) by...
The age-related macular degeneration market is predicted to reach USD 14.98 billion by 2030 at 8.1% CAGR during the forecast period 2022-2030.
The growing awareness of AMD and the increasing geriatric population are anticipated to exhibit more opportunities for the growth of the age-related macular degeneration market. Moreover, as per the Community Eye Health Journal published in...
The global market for age-related macular degenerations market size is expected to grow at a CAGR of approximately 7.3% during the forecast period.
The growing awareness of AMD and the increasing geriatric population are anticipated to exhibit more opportunities for the growth of the age-related macular degeneration market. Moreover, as per the Community Eye Health Journal published in...
According to recent market research, the Dry Age-Related Macular Degeneration Market Size was valued at USD 11.12 billion in 2022. Projections indicate a substantial growth trajectory, with expectations to reach USD 20.92 billion by 2030. This phenomenal growth is anticipated to occur at a Compound Annual Growth Rate (CAGR) of 8.22% over the forecast period from 2023 to 2030. These figures...
Dry Age-Related Macular Degeneration Market Analysis
A landmark market research report reveals that the global Dry Age-Related Macular Degeneration (AMD) Market is on a robust growth trajectory, projected to nearly double from its 2023 valuation of $12.03 billion to a substantial $22.64 billion by 2031. This forecast reflects a strong Compound Annual Growth Rate (CAGR) of 8.22% over the...